SCHEMBL19631491

SCHEMBL19631491

O=Cc1ccccc1C(=O)OC1CCCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
MMP9 P14780 3/20 0.46
MMP12 P39900 3/20 0.46
MMP1 P03956 2/20 0.46
MMP2 P08253 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
POLB P06746 1/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ADRA1A P35348 1/20 0.43
SCN1A P35498 3/20 0.42
SCN2A Q99250 3/20 0.42
SCN3A Q9NY46 3/20 0.42
SRC P12931 1/20 0.42
FABP7 O15540 1/20 0.41
FABP5 Q01469 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30131126 1.00 MEN1 (0.49) MEN1KMT2ANPC1RAB9AMMP9
SCHEMBL3363106 0.86 MEN1 (0.48) MEN1KMT2ANPC1RAB9AMMP9
SCHEMBL29302 0.85 MEN1 (0.57) MEN1KMT2ANPC1RAB9AMMP9
SCHEMBL31069910 0.85 MEN1 (0.57) MEN1KMT2ANPC1RAB9AMMP9
SCHEMBL8607117 0.85 MEN1 (0.57) MEN1KMT2ANPC1RAB9AMMP9
SCHEMBL10707097 0.85 MEN1 (0.57) MEN1KMT2ANPC1RAB9AMMP9
SCHEMBL19668120 0.85 MEN1 (0.57) MEN1KMT2ANPC1RAB9AMMP9
SCHEMBL29372521 0.85 MEN1 (0.57) MEN1KMT2ANPC1RAB9AMMP9
SCHEMBL23275566 0.83 MMP9 (0.53) MEN1KMT2ANPC1RAB9AMMP9
SCHEMBL3361977 0.83 MEN1 (0.55) MEN1KMT2ANPC1RAB9AMMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11534427-B2 Applications of novel thiazole derivative in treating inflammatory bowel diseases EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2022-12-27 US disclosed
EP-3459937-B1 THIAZOLE DERIVATIVE AND APPLICATIONS UNIV EAST CHINA SCIENCE & TECH (CN) 2021-12-29 EP disclosed
US-10919869-B2 Thiazole derivative and applications EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2021-02-16 US disclosed
US-20190290620-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-09-26 US disclosed
US-20190292162-A1 THIAZOLE DERIVATIVE AND APPLICATIONS EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-09-26 US disclosed
EP-3459937-A1 THIAZOLE DERIVATIVE AND APPLICATIONS East China University of Science and Technology (CN) 2019-03-27 EP disclosed
WO-2017198179-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES 华东理工大学 2017-11-23 WO disclosed
WO-2017198178-A1 THIAZOLE DERIVATIVE AND APPLICATIONS 华东理工大学 2017-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11534427-B2 Applications of novel thiazole derivative in treating inflammatory bowel diseases FABP2, SLC10A2, ALPI MEN1 4844/4885KMT2A 4681/4885NPC1 1994/4885
US-20190292162-A1 THIAZOLE DERIVATIVE AND APPLICATIONS DHODH, DLD, THOC2 MEN1 3352/4885KMT2A 4625/4885NPC1 420/4885
US-20190290620-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES FABP2, SLC10A2, ALPI MEN1 4844/4885KMT2A 4681/4885NPC1 1994/4885
US-10919869-B2 Thiazole derivative and applications DHODH, DLD, THOC2 MEN1 3352/4885KMT2A 4625/4885NPC1 420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.